Sun Pharmaceutical to acquire 16.33% stake in Surgimatix

21 Feb 2024 Evaluate

Sun Pharmaceutical Industries has entered into an agreement with Surgimatix, Inc to acquire 16.33% shares of Surgimatix, Inc. The cost of acquisition is around $3.05 million. 

Surgimatix, Inc. is engaged in the business of developing a proprietary soft tissue fixation device for laparoscopic hernia repair and other minimally invasive surgeries. The company was incorporated on November 19, 2007. Surgimatix, Inc. is yet to commence its commercial operations.

Sun Pharmaceutical Industries is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1560.40 -43.60 (-2.72%)
12-Apr-2024 10:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1560.40
Dr. Reddys Lab 6170.00
Cipla 1414.00
Zydus Lifesciences 985.40
Lupin 1634.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.